Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rhodiola rosea in Adults With ADHD
NCT02737020Phase 4Unknown
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- Apr 2016
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Vitano in attention deficit hyperactivity disorder (ADHD), sponsored by Hospital de Clínicas de Porto Alegre. Status: unknown.
02
Drugs
Vitano
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT02737020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02737020.